{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:38:57Z","timestamp":1791326337440,"version":"4.3.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"29","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>This study aimed to evaluate clinical outcomes in patients developing post-operative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) and characterize variations in oral anticoagulation (OAC) use, benefits, and complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search identified studies on new-onset POAF after CABG and OAC initiation. Outcomes included risks of thromboembolic events, bleeding, and mortality. Furthermore, a meta-analysis was conducted on these outcomes, stratified by the use or non-use of OAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The identified studies were all non-randomized. Among 1 698 307 CABG patients, POAF incidence ranged from 7.9% to 37.6%. Of all POAF patients, 15.5% received OAC. Within 30 days, thromboembolic events occurred at rates of 1.0% (POAF: 0.3%; non-POAF: 0.8%) with 2.0% mortality (POAF: 1.0%; non-POAF: 0.5%). Bleeding rates were 1.1% for POAF patients and 2.7% for non-POAF patients. Over a median of 4.6 years, POAF patients had 1.73 thromboembolic events, 3.39 mortality, and 2.00 bleeding events per 100 person-years; non-POAF patients had 1.14, 2.19, and 1.60, respectively. No significant differences in thromboembolic risks [effect size \u22120.11 (\u22120.36 to 0.13)] and mortality [effect size \u22120.07 (\u22120.21 to 0.07)] were observed between OAC users and non-users. However, OAC use was associated with higher bleeding risk [effect size 0.32 (0.06\u20130.58)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In multiple timeframes following CABG, the incidence of complications in patients who develop POAF is low. The use of OAC in patients with POAF after CABG is associated with increased bleeding risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehae267","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:16:35Z","timestamp":1713280595000},"page":"2620-2630","source":"Crossref","is-referenced-by-count":30,"title":["Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-9404","authenticated-orcid":false,"given":"Mileen R D","family":"van de Kar","sequence":"first","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6933-1797","authenticated-orcid":false,"given":"Thomas J","family":"van Brakel","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-0111","authenticated-orcid":false,"given":"Marcel","family":"van\u2019t Veer","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology , Eindhoven , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-7014","authenticated-orcid":false,"given":"Gijs J","family":"van Steenbergen","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-7974","authenticated-orcid":false,"given":"Edgar J","family":"Daeter","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Antonius Hospital , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-5337","authenticated-orcid":false,"given":"Harry J G M","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiovascular Research Centre Maastricht (CARIM), Maastricht UMC+ , Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-9203","authenticated-orcid":false,"given":"Dennis","family":"van Veghel","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-3716","authenticated-orcid":false,"given":"Lukas R C","family":"Dekker","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology , Eindhoven , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-8648","authenticated-orcid":false,"given":"Luuk C","family":"Otterspoor","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiothoracic Surgery, Catharina Hospital , P.O. Box 1350, Eindhoven 5602 ZA , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"2024080310540029200_ehae267-B1","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.114.014058","article-title":"Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study","volume":"131","author":"Lubitz","year":"2015","journal-title":"Circulation"},{"key":"2024080310540029200_ehae267-B2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: mechanisms, manifestations and management","volume":"16","author":"Dobrev","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2024080310540029200_ehae267-B3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.athoracsur.2010.03.083","article-title":"The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting","volume":"90","author":"Bramer","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2024080310540029200_ehae267-B4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jtcvs.2017.02.052","article-title":"New-onset postoperative atrial fibrillation after aortic valve replacement: effect on long-term survival","volume":"154","author":"Swinkels","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024080310540029200_ehae267-B5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","article-title":"Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery","volume":"51","author":"Echahidi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jacc.2003.12.011","article-title":"Postoperative atrial fibrillation and mortality: do the risks merit changes in clinical practice?","volume":"43","author":"Levy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-5223(97)70142-9","article-title":"Outcome of atrial fibrillation after mitral valve repair","volume":"114","author":"Obadia","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024080310540029200_ehae267-B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1445-5994.1985.tb02726.x","article-title":"Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy","volume":"15","author":"Gavaghan","year":"1985","journal-title":"Aust N Z J Med"},{"key":"2024080310540029200_ehae267-B9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ejcts\/ezu551","article-title":"New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis","volume":"48","author":"Phan","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024080310540029200_ehae267-B10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024080310540029200_ehae267-B11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2024080310540029200_ehae267-B13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cjco.2021.09.011","article-title":"Short-term and long-term risk of stroke in patients with perioperative atrial fibrillation after cardiac surgery: systematic review and meta-analysis","volume":"4","author":"Wang","year":"2022","journal-title":"CJC Open"},{"key":"2024080310540029200_ehae267-B14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cjca.2020.08.023","article-title":"Anticoagulant use and the risk of thromboembolism and bleeding in postoperative atrial fibrillation after noncardiac surgery","volume":"37","author":"Elharram","year":"2021","journal-title":"Can J Cardiol"},{"key":"2024080310540029200_ehae267-B15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024080310540029200_ehae267-B16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3949\/ccjm.89a.21003","article-title":"Anticoagulation management of post-cardiac surgery new-onset atrial fibrillation","volume":"89","author":"Alhatemi","year":"2022","journal-title":"Cleve Clin J Med"},{"key":"2024080310540029200_ehae267-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2024080310540029200_ehae267-B18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2024080310540029200_ehae267-B19","author":"R Core Team"},{"key":"2024080310540029200_ehae267-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analysis in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"2024080310540029200_ehae267-B21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"2024080310540029200_ehae267-B22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"2024080310540029200_ehae267-B23","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2024080310540029200_ehae267-B24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jtcvs.2020.01.077","article-title":"Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: prescription patterns and 30-day outcomes in the United States and Canada","volume":"162","author":"Matos","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024080310540029200_ehae267-B25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.hroo.2022.06.003","article-title":"Anticoagulation in new-onset postoperative atrial fibrillation: an analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database","volume":"3","author":"Riad","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"2024080310540029200_ehae267-B26","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.athoracsur.2020.12.031","article-title":"Non-vitamin K antagonist oral anticoagulant vs warfarin for post cardiac surgery atrial fibrillation","volume":"112","author":"Nauffal","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2024080310540029200_ehae267-B27","doi-asserted-by":"crossref","first-page":"e017966","DOI":"10.1161\/JAHA.120.017966","article-title":"New-Onset atrial fibrillation after coronary artery bypass grafting and long-term outcome: a population-based nationwide study from the SWEDEHEART registry","volume":"10","author":"Taha","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2024080310540029200_ehae267-B28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jacc.2009.10.058","article-title":"New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft","volume":"55","author":"El-Chami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jocs.12033","article-title":"New onset postoperative atrial fibrillation is associated with a long-term risk for stroke and death following cardiac surgery","volume":"28","author":"Horwich","year":"2013","journal-title":"J Card Surg"},{"key":"2024080310540029200_ehae267-B30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamacardio.2018.0405","article-title":"Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation","volume":"3","author":"Butt","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2024080310540029200_ehae267-B31","doi-asserted-by":"crossref","first-page":"e8032","DOI":"10.1161\/JAHA.122.027010","article-title":"Risk and subtypes of stroke following new-onset postoperative atrial fibrillation in coronary bypass surgery: a population-based cohort study","volume":"11","author":"Feilberg Rasmussen","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2024080310540029200_ehae267-B32","first-page":"365","article-title":"Transient post-operative atrial fibrillation predicts short and long term adverse events following CABG","volume":"4","author":"Philip","year":"2014","journal-title":"Cardiovasc Diagn Ther"},{"key":"2024080310540029200_ehae267-B33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2003.11.023","article-title":"Postoperative atrial fibrillation and mortality after coronary artery bypass surgery","volume":"43","author":"Villareal","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B34","doi-asserted-by":"crossref","first-page":"e020426","DOI":"10.1161\/JAHA.120.020426","article-title":"New-onset perioperative atrial fibrillation after coronary artery bypass grafting and long-term risk of adverse events: an analysis from the CORONARY trial","volume":"10","author":"Conen","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2024080310540029200_ehae267-B35","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.120.046940","article-title":"Postoperative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery","volume":"142","author":"Benedetto","year":"2020","journal-title":"Circulation"},{"key":"2024080310540029200_ehae267-B36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ahj.2009.09.003","article-title":"Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: results from the PRoject of Ex-vivo Vein graft ENgineering via transfection IV (PREVENT-IV)","volume":"158","author":"Al-Khatib","year":"2009","journal-title":"Trial. Am Heart J"},{"key":"2024080310540029200_ehae267-B37","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.108.777789","article-title":"Atrial fibrillation after isolated coronary surgery affects late survival","volume":"118","author":"Mariscalco","year":"2008","journal-title":"Circulation"},{"key":"2024080310540029200_ehae267-B38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.thromres.2015.02.015","article-title":"Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery","volume":"135","author":"Schulman","year":"2015","journal-title":"Thromb Res"},{"key":"2024080310540029200_ehae267-B39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.hlc.2020.04.018","article-title":"Novel oral anticoagulants compared to warfarin for postoperative atrial fibrillation after isolated coronary artery bypass grafting","volume":"29","author":"Woldendorp","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2024080310540029200_ehae267-B40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9149(00)00829-8","article-title":"Atrial fibrillation after beating heart surgery","volume":"86","author":"Stamou","year":"2000","journal-title":"Am J Cardiol"},{"key":"2024080310540029200_ehae267-B41","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.amjsurg.2015.07.005","article-title":"Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis","volume":"210","author":"Anderson","year":"2015","journal-title":"Am J Surg"},{"key":"2024080310540029200_ehae267-B42","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ejcts.2009.12.033","article-title":"Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality","volume":"37","author":"Ahlsson","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024080310540029200_ehae267-B43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacc.2017.12.012","article-title":"New-onset atrial fibrillation after PCI or CABG for left main disease: the EXCEL trial","volume":"71","author":"Kosmidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ejcts\/ezu526","article-title":"New-onset atrial fibrillation at discharge in patients after coronary artery bypass surgery: short- and long-term morbidity and mortality","volume":"48","author":"Tulla","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024080310540029200_ehae267-B45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0167-5273(01)00622-2","article-title":"Atrial fibrillation after coronary surgery: comparison between different health care systems","volume":"82","author":"Majahalme","year":"2002","journal-title":"Int J Cardiol"},{"key":"2024080310540029200_ehae267-B46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1460-9592.2001.00191.x","article-title":"Clinical outcome of patients who develop PAF after CABG surgery","volume":"24","author":"Kowey","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024080310540029200_ehae267-B47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1542-474X.2006.00095.x","article-title":"Patterns of atrial fibrillation after coronary artery bypass surgery","volume":"11","author":"Tamis-Holland","year":"2006","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2024080310540029200_ehae267-B48","doi-asserted-by":"crossref","first-page":"E580","DOI":"10.1532\/hsf.3857","article-title":"The gap in prescribing stroke prevention therapies in postoperative atrial fibrillation after isolated coronary artery bypass grafting surgery","volume":"24","author":"Shurrab","year":"2021","journal-title":"Heart Surg Forum"},{"key":"2024080310540029200_ehae267-B49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12055-022-01358-7","article-title":"Incidence, predictors, and outcome for post-operative atrial fibrillation in Indian patients undergoing off-pump coronary artery bypass grafting-a prospective observational study","volume":"38","author":"Potdar","year":"2022","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"2024080310540029200_ehae267-B50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1074248420929483","article-title":"Comparison of anticoagulants for postoperative atrial fibrillation after coronary artery bypass grafting: a pilot study","volume":"25","author":"Chapin","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2024080310540029200_ehae267-B51","first-page":"744","article-title":"Postoperative atrial fibrillation following coronary artery bypass graft surgery predicts long-term atrial fibrillation and stroke","volume":"18","author":"Konstantino","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"2024080310540029200_ehae267-B52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2024080310540029200_ehae267-B53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12959-021-00342-2","article-title":"Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis","volume":"19","author":"Frag\u00e3o-Marques","year":"2021","journal-title":"Thromb J"},{"key":"2024080310540029200_ehae267-B54","first-page":"e42880","article-title":"The management of postoperative atrial fibrillation (POAF): a systematic review","volume":"15","author":"Meenashi Sundaram","year":"2023","journal-title":"Cureus"},{"key":"2024080310540029200_ehae267-B55","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389:","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2024080310540029200_ehae267-B56","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024080310540029200_ehae267-B57","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"2024080310540029200_ehae267-B58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"2024080310540029200_ehae267-B59","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-Pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"2024080310540029200_ehae267-B60","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"2024080310540029200_ehae267-B61","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"2024080310540029200_ehae267-B62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study","volume":"376","author":"O\u2019Donnell","year":"2010","journal-title":"Lancet"},{"key":"2024080310540029200_ehae267-B63","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cjco.2022.06.003","article-title":"Use of anticoagulation therapy in patients with perioperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2022","journal-title":"CJC Open"},{"key":"2024080310540029200_ehae267-B64","first-page":"869","article-title":"Left atrial appendage occlusion: rationale, evidence, devices, and patient selection","volume":"38","author":"Piccini","year":"2017","journal-title":"Eur Heart J"},{"key":"2024080310540029200_ehae267-B65","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/eurheartj\/ehr393","article-title":"Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation","volume":"33","author":"Landmesser","year":"2012","journal-title":"Eur Heart J"},{"key":"2024080310540029200_ehae267-B66","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2024080310540029200_ehae267-B67","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/eurheartj\/ehw048","article-title":"Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation","volume":"37","author":"Panikker","year":"2016","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/29\/2620\/58724020\/ehae267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/29\/2620\/58724020\/ehae267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:54:45Z","timestamp":1722668085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/29\/2620\/7684756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":67,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2024,5,29]]},"published-print":{"date-parts":[[2024,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae267","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8,1]]},"published":{"date-parts":[[2024,5,29]]}}}